Author

Charles L. Daley

National Jewish HealthORCID 0000-0003-3324-926XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Paul Alivisatos· 1 shared Barry N. KreiswirthiD· 1 shared Bree B. AldridgeiD· 1 shared Christopher R. BetheliD· 1 shared David C. NguyeniD· 1 shared Eunjeong ShiniD· 1 shared Husain PoonawalaiD· 1 shared Kathleen P. DavisiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Paul Alivisatos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewedApr 6, 2026

Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum

Husain Poonawala, Kathleen P. Davis, Myles E. Kenny…·Bree B. Aldridge

This study uses dose-response curves to measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum, showing that IC50 and IC75 are more consistent than MIC.

2 citationstop 4%

humanexperimental assay

𝕏 PostBluesky

MicrobiologymBioPeer-reviewedMay 14, 2024

Synergistic Effects of Sulopenem in Combination with Cefuroxime or Durlobactam against Mycobacterium abscessus

Khalid M Dousa, Eunjeong Shin, Sebastian G. Kurz…·Robert A. Bonomo

This study shows that sulopenem combined with cefuroxime or durlobactam synergistically inhibits Mycobacterium abscessus, with BLIs enhancing antibacterial effects.

21 citationstop 3%

humanexperimental assay

𝕏 PostBluesky